Загрузка...
Therapeutic Targets for the Treatment of Cardiac Fibrosis and Cancer: Focusing on TGF-β Signaling
Transforming growth factor-β (TGF-β) is a common mediator of cancer progression and fibrosis. Fibrosis can be a significant pathology in multiple organs, including the heart. In this review, we explain how inhibitors of TGF-β signaling can work as antifibrotic therapy. After cardiac injury, profibro...
Сохранить в:
| Опубликовано в: : | Front Cardiovasc Med |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7075814/ https://ncbi.nlm.nih.gov/pubmed/32211422 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcvm.2020.00034 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|